Prophylactic surgeries prevent two gynecological cancers in women with Lynch syndrome

January 18, 2006

HOUSTON - Women diagnosed with Lynch syndrome, a condition often associated with colon cancer, also are at high risk for endometrial and ovarian cancers - both of which can be eliminated by having a prophylactic hysterectomy and oophorectomy (removal of the ovaries), according to a study published by researchers from The University of Texas M. D. Anderson Cancer Center in the Jan. 19 New England Journal of Medicine.

Lynch syndrome, also called hereditary nonpolyposis colon cancer, is an inherited disorder in which affected individuals have a much higher-than-normal chance of developing colon cancer and/or certain other types of cancer, usually before the age of 60. About one in 1,000 individuals carry the gene mutation that causes Lynch syndrome, which accounts for approximately five percent of all colon (in men and women) and endometrial cancers, and two percent of all ovarian cancers, according to Karen Lu, M.D., associate professor in M. D. Anderson's Department of Gynecologic Oncology.

"The key reason that we embarked on this study was that women with Lynch syndrome have an equal risk of developing endometrial and colon cancers, and often develop additional cancers. However, for the last 20 years, the majority of the Lynch syndrome research has been focused on colon cancer risk. Often, women who have this condition don't even realize that they also are at risk for two gynecological cancers, and their risk is extremely high."

Women with the condition have a 40 percent to 60 percent lifetime risk of developing endometrial cancer, and a 10 percent to 12 percent lifetime risk of ovarian cancer, says Lu, the study's corresponding author. By comparison, in the general population, a woman's risk of developing endometrial cancer is about three percent, and a woman's risk of developing ovarian cancer is one percent to two percent.

To determine that the preventative surgeries reduced the risk for endometrial and ovarian cancers, Lu and her colleagues retrospectively evaluated 315 women with Lynch syndrome. For preventative reasons or to treat benign conditions, 61 of these women had undergone a prophylactic hysterectomy; 47 also had their ovaries removed. All of the other 254 women, the control group, had not undergone any prophylactic surgeries.

No endometrial and/or ovarian cancers were diagnosed in the women who had undergone the prophylactic surgeries. However, 69 women (33 percent) in the control group were diagnosed with endometrial cancer; 12 women (5 percent) in the control group were diagnosed with ovarian cancer.

"For women who have this condition and are at an extremely high risk for two gynecological cancers, this study provides a positive finding. We now have definitive evidence for doing something proactively that will prevent women with Lynch syndrome from ever getting either endometrial, or ovarian cancers, or even both," Lu says.

In the medical community, Lu says, there is little awareness of the link between endometrial and colon cancers, despite there being equal risk of women with the condition to develop both diseases.

"This study is a very important reminder to physicians to pay particular attention to a woman's family history of colon, endometrial and ovarian cancers, with genetic counseling becoming of utmost importance. If women with Lynch syndrome are identified, there needs to be coordinated care between the gastrointestinal and obstetrics and gynecologic medical disciplines," Lu says.

Given that the average age of developing endometrial cancer was 46 among the women in the study, typically, women can wait until after child-bearing years to have the surgery, Lu says.
The study was funded, in part, by a grant from the National Cancer Institute. Other M. D. Anderson authors on the study include: Kathleen M. Schmeler, M.D.; Mark F. Munsell; Pamela T. Soliman, M.D.; Molly S. Daniels; Kristin G. White; Stephanie G. Boyd-Rogers; Charlotte Sun; Brian M. Slomovitz, M.D.; David M. Gershenson, M.D. Authors Henry T. Lynch, M.D. and Mary Beth Clark are from Creighton University; authors Lee-May Chen, M.D., Kathleen Y. Yang, M. D., Mary M. Rubin, Ph.D., and Peggy G. Conrad are from the University of California at San Francisco.

Contact: Laura Sussman,; (713) 745-2457

University of Texas M. D. Anderson Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to